 |
|
Sign in to view your progression
|
|
ON-DEMAND
Molecular profiling of NSMP high-risk endometrial cancers of the PORTEC-3 trial – prognostic refinement and druggable targets
|
|
|
ON-DEMAND
Molecular classification of endometrial carcinoma substantially changing risk-assessment: Results from a european multicentre initiative.
|
|
|
ON-DEMAND
Dostarlimab in advanced/recurrent mismatch repair deficient/microsatellite instability high or proficient/stable endometrial cancer: the GARNET study
|
|
|
ON-DEMAND
Real-world patterns of care and outcomes in patients with microsatellite-instability high tumors in advanced endometrial cancer in the United States
|
|
|
Q&A
Q&A
|
|
{{ help_message }}
{{filter}}